Chemotherapeutic Agents Can Activate the cGAS‐STING Pathway, and cGAS Inhibition Enhances the Tumor‐Killing Effect in PTCL. The gene discussed is STING1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.